Paroxysmal sympathetic hyperactivity in brain damage (scientific review). Part 2
Open Access
- 6 May 2025
- journal article
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 21 (3) , 320-27
Abstract
Currently, there is no generally accepted method for elimination of centrogenic hyperthermic reactions. In paroxysmal sympathetic hyperactivity, body temperature should be maintained in a safe normothermic range for at least the first few days. The potential benefits of treatment may result from three primary goals: elimination of triggering factors, mitigation of excessive sympathetic overload, and supportive therapy. Treatment involves reducing any external stimulation that can trigger paroxysmal episodes. Because fever is caused by a prostaglandin-induced shift in the hypothalamic “set point”, conventional nonsteroidal anti-inflammatory drugs inhibit prostaglandin synthesis, but centrogenic hyperthermic reactions are mostly resistant to antipyretic therapy. Physical cooling is used when medical treatment is ineffective. Endovascular cooling methods are more effective than external ones. Monotherapy for paroxysmal sympathetic hyperactivity is usually ineffective, so the possibility of using several drugs with different mechanisms of action should be considered. The use of moderate doses of several drug classes provides synergistic efficacy, reducing the toxicity of individual drugs. Multimodal treatment regimens are more effective than monotherapy. The lack of a generally accepted technique for elimination of centrogenic hyperthermic reactions requires further multicenter studies and the creation of appropriate clinical guidelines.Keywords
This publication has 34 references indexed in Scilit:
- Paroxysmal Sympathetic Hyperactivity After Acquired Brain Injury: An Integrative Review of Diagnostic and Management ChallengesNeurology and Therapy, 2023
- Targeted Temperature Management After In-Hospital Cardiac ArrestChest, 2022
- Impact of Fever Prevention in Brain-Injured Patients (INTREPID): Study Protocol for a Randomized Controlled TrialNeurocritical Care, 2021
- The effectiveness of early prophylactic hypothermia in adult patients with traumatic brain injury: A systematic review and meta-analysisAustralian Critical Care, 2021
- Temperature management in acute brain injury: A systematic review of clinical evidenceClinical Neurology and Neurosurgery, 2020
- Paroxysmal sympathetic hyperactivity: An entity to keep in mindMedicina Intensiva (English Edition), 2019
- Targeted temperature management in patients with intracerebral haemorrhage, subarachnoid haemorrhage, or acute ischaemic stroke: consensus recommendationsBritish Journal of Anaesthesia, 2018
- Paroxysmal sympathetic hyperactivity: the storm after acute brain injuryThe Lancet Neurology, 2017
- Long‐Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain InjuryPM&R, 2017
- Treatment of paroxysmal sympathetic hyperactivityCurrent Treatment Options in Neurology, 2008